Muscle Relaxant Drugs Market, By Drug Type (Skeletal Muscle Relaxant Drugs (e.g., cyclobenzaprine, baclofen, etc.) , Neuromuscular Blocking Agents (e.g., rocuronium, succinylcholine, etc.), and Facial Muscle Relaxant Drugs (primarily botulinum toxin-based products like Botox, Dysport, Xeomin)), By Drug Class (Centrally Acting Muscle Relaxants and Peripherally Acting Muscle Relaxants), By Dosage Form (Tablet, Capsule, Liquid, and Others (Gel, Ointments and Sprays etc.)), By Route of Administration (Oral, Parenteral (Injectables), and Topical), By Application (Muscle Spasm and Pain Relief, Musculoskeletal Disorders, Surgical Anesthesia, and Others (e.g., Fibromyalgia, etc.)), By Age Group (Adult, Pediatric, and Geriatric), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Product Type (Branded and Generic), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)